faricimab
E238184
UNEXPLORED
Faricimab is a bispecific monoclonal antibody used to treat neovascular eye diseases such as wet age-related macular degeneration and diabetic macular edema by targeting both VEGF-A and Ang-2 pathways.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.